Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance

Two Letters to Blood address the risks of COVID-19 in populations with precursors of hematological disease. In the first article, Miller and colleagues report on whether clonal hematopoiesis of intermediate potential (CHIP) is associated with adverse outcomes with COVID-19, finding no association be...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Matthew, Zanwar, Saurabh, Buadi, Francis K., Ailawadhi, Sikander, Larsen, Jeremy, Bergsagel, Leif, Binder, Moritz, Chanan-Khan, Asher, Dingli, David, Dispenzieri, Angela, Fonseca, Rafael, Gertz, Morie A., Gonsalves, Wilson, Go, Ronald S., Hayman, Suzanne, Kapoor, Prashant, Kourelis, Taxiarchis, Lacy, Martha Q., Leung, Nelson, Lin, Yi, Muchtar, Eli, Roy, Vivek, Sher, Taimur, Warsame, Rahma, Fonder, Amie, Hobbs, Miriam, Hwa, Yi L., Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Letter to Blood
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474409/
https://www.ncbi.nlm.nih.gov/pubmed/36096078
http://dx.doi.org/10.1182/blood.2022017616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474409/
https://www.ncbi.nlm.nih.gov/pubmed/36096078
http://dx.doi.org/10.1182/blood.2022017616

Ejemplares similares